The mSHOX2 is capable of assessing the therapeutic effect and predicting the prognosis of stage IV lung cancer

BACKGROUND: Instant monitoring of the therapeutic effect of systematic therapy in late-stage lung cancer is crucial for response assessment and strategy adjustment. Previous study found that specific plasma methylation markers may be applied to therapeutic effect assessment. In order to investigate...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thorac Dis
Hlavní autoři: Peng, Xiumei, Liu, Xiaoliang, Xu, Long, Li, Yuemin, Wang, Huaiqing, Song, Lele, Xiao, Wenhua
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6626805/
https://ncbi.nlm.nih.gov/pubmed/31372283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.05.81
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky